文献速递心血管胸部CT

冠状动脉CTA与CT-FFR在经导管主动脉瓣植入候选者中的应用:系统综述与Meta分析

Coronary CTA and CT-FFR in trans-catheter aortic valve implantation candidates: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2024-12-31

该系统综述与Meta分析纳入34篇文献,评估冠状动脉CTA与CT-FFR在TAVI候选者中识别和排除阻塞性冠心病的效能;患者水平汇总CCTA敏感度94.0%、特异度72.4%,CT-FFR敏感度93.2%、特异度70.3%;直接对比研究中CT-FFR表现优于CCTA,但多数研究样本量小且CT-FFR软件仅限科研使用。

要点

  • 阴性CCTA可准确排除TAVI人群阻塞性冠心病,但假阳性率仍高。
  • 直接对比研究中CT-FFR敏感度83.9%、特异度89.8%,均优于CCTA的74.9%和65.5%。
  • 多数CT-FFR研究样本量小且软件仅限科研使用,常规开展前需用商用软件开展大型研究。

核心结论

  • 阴性CCTA可准确排除TAVI人群阻塞性冠心病,CCTA可显著减少TAVI术前有创冠状动脉造影,但假阳性仍高;本Meta分析中CT-FFR诊断准确性与CCTA相当,但直接对比研究中CT-FFR优于CCTA;多数研究样本量小且CT-FFR软件仅限科研使用,在考虑常规开展前需用商用CT-FFR软件开展大型研究。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase和Web of Science,纳入34篇关于TAVI候选者CCTA和/或CT-FFR的研究,CCTA汇总7235例患者、CT-FFR汇总1269例患者,参考标准多为冠心病解剖严重程度。

诊断标准与关键数值

  • 患者水平汇总CCTA敏感度94.0%、特异度72.4%;CT-FFR敏感度93.2%、特异度70.3%,研究间变异大;直接对比研究中CCTA敏感度74.9%、特异度65.5%,CT-FFR敏感度83.9%、特异度89.8%。

临床应用与阅片要点

  • 在TAVI术前评估中,可将冠状动脉CTA加入TAVI规划CT以筛查阻塞性冠心病,可能减少阴性有创冠状动脉造影;CT-FFR可能减少CCTA假阳性结果、改善其守门人功能,但需更多数据;作者认为在考虑常规开展前需用商用CT-FFR软件开展大型研究。

局限性

  • 多数研究样本量小。
  • 多数研究使用的CT-FFR软件仅限科研使用。
  • CT-FFR汇总结果研究间变异大。
  • 作者认为在考虑常规开展前需用商用CT-FFR软件开展大型研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Screening for obstructive coronary artery disease (CAD) with coronary computed tomography angiography (CCTA) could prevent unnecessary invasive coronary angiography (ICA) procedures during work-up for trans-catheter aortic valve implantation (TAVI). CT-derived fractional flow reserve (CT-FFR) improves CCTA accuracy in chest pain patients. However, its reliability in the TAVI population is unknown. This systematic review and meta-analysis assesses CCTA and CT-FFR in TAVI candidates.

METHODS: PubMed, Embase and Web of Science were searched for studies regarding CCTA and/or CT-FFR in TAVI candidates. Primary endpoint was correct identification and rule-out of obstructive CAD. Results were pooled in a meta-analysis.

RESULTS: Thirty-four articles were part of the meta-analysis, reporting results for CCTA and CT-FFR in 7235 and 1269 patients, respectively. Reference standard was mostly anatomical severity of CAD. At patient level, pooled CCTA sensitivity was 94.0% and specificity 72.4%. CT-FFR sensitivity was 93.2% and specificity 70.3% with substantial variation between studies. However, in studies that compared both, CT-FFR performed better than CCTA. Sensitivity of CCTA versus CT-FFR was 74.9% versus 83.9%, and specificity was 65.5% versus 89.8%.

CONCLUSIONS: Negative CCTA accurately rules out CAD in the TAVI population. CCTA could lead to significant reduction in pre-TAVI ICA, but false positives remain high. Diagnostic accuracy of CT-FFR was comparable to that of CCTA in our meta-analyses, but in studies performing a direct comparison, CT-FFR performed better than CCTA. However, as most studies were small and used CT-FFR software exclusively available for research, a large study on CT-FFR in TAVI work-up using commercially available CT-FFR software would be appropriate before considering routine implementation.

KEY POINTS: Question Coronary artery disease (CAD) screening with invasive coronary angiography before trans-catheter aortic valve implantation (TAVI) is often retrospectively unnecessary, revealing no obstructive CAD. Findings Coronary CTA ruled out CAD in approximately half of TAVI candidates. CT-derived fractional flow reserve (CT-FFR) performed similarly overall but better than coronary CTA in direct comparison. Clinical relevance Addition of coronary CTA to TAVI planning-CT to screen for obstructive CAD could reduce negative invasive coronary angiographies in TAVI work-up. CT-FFR could reduce false-positive coronary CTA results, improving its gatekeeper function in this population, but more data is necessary.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Becker LM, Peper J, van Ginkel DJ, et al. Coronary CTA and CT-FFR in trans-catheter aortic valve implantation candidates: a systematic review and meta-analysis. Eur Radiol. 2024. PMID: 39738560. doi:10.1007/s00330-024-11211-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。